June 2026
The global lentiviral vector market size is projected to surpass around USD 2,175.41 million by 2035 increasing from USD 413.21 million in 2025, with a CAGR of 18.07%.
June 2026
The US viral vectors and plasmid DNA manufacturing market size is valued at USD 3.30 billion in 2025 and is predicted to hit USD 11.69 billion by 2035, with a CAGR of 15.20%.
May 2026
The viral vectors and plasmid DNA manufacturing market size is expected to hit USD 29.82 billion by 2035 from USD 7.26 billion in 2025 with a CAGR of 15.17%.
May 2026
The global viral and non-viral vectors market size was evaluated at USD 9.40 billion in 2025 and is predicted to hit around USD 48.37 billion by 2035, growing at a CAGR of 17.80%.
March 2026
The global adeno associated virus vector manufacturing market size is anticipated at USD 1.56 billion in 2025 and is predicted to hit around USD 11.72 billion by 2035 and it is growing at a CAGR of 22.34% from 2026 to 2035.
December 2025
The global next generation vector engineering market is fueled by technological innovations, increasing R&D activities, and the rising adoption of advanced genetic tools.
November 2025
The global torque vectoring market size is expected to surge around USD 41.22 billion by 2034, increasing from USD 13.01 billion in 2025, with a CAGR of 13.67%.
July 2025
The global viral vectors based gene therapy for non-human primates market size is estimated to hit around USD 5.46 billion by 2034 from USD 1.3 billion in 2024, with a CAGR of 15.44%.
June 2025
The global viral vectors for non human primates market size is estimated to hit around USD 397.87 million by 2034 from USD 145.8 million in 2024, at a CAGR of 10.56%.
July 2025
The next?gen delivery systems for genetic drug market is expanding with lipid nanoparticles, viral vectors, and extracellular vesicles enabling precision gene delivery.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com